- Home
- AAP vs APGE Comparison
AAP vs APGE Comparison
Compare AAP & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- APGE
- Stock Information
- Founded
- AAP 1929
- APGE 2022
- Country
- AAP United States
- APGE United States
- Employees
- AAP N/A
- APGE N/A
- Industry
- AAP Auto & Home Supply Stores
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AAP Consumer Discretionary
- APGE Health Care
- Exchange
- AAP Nasdaq
- APGE Nasdaq
- Market Cap
- AAP 2.8B
- APGE 3.0B
- IPO Year
- AAP N/A
- APGE 2023
- Fundamental
- Price
- AAP $45.94
- APGE $37.06
- Analyst Decision
- AAP Hold
- APGE Strong Buy
- Analyst Count
- AAP 15
- APGE 5
- Target Price
- AAP $46.40
- APGE $83.50
- AVG Volume (30 Days)
- AAP 1.8M
- APGE 488.2K
- Earning Date
- AAP 02-26-2025
- APGE 03-04-2025
- Dividend Yield
- AAP 2.18%
- APGE N/A
- EPS Growth
- AAP N/A
- APGE N/A
- EPS
- AAP 0.73
- APGE N/A
- Revenue
- AAP $11,191,239,000.00
- APGE N/A
- Revenue This Year
- AAP N/A
- APGE N/A
- Revenue Next Year
- AAP N/A
- APGE N/A
- P/E Ratio
- AAP $58.20
- APGE N/A
- Revenue Growth
- AAP 15.75
- APGE N/A
- 52 Week Low
- AAP $35.59
- APGE $31.75
- 52 Week High
- AAP $88.56
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- AAP 54.70
- APGE 32.29
- Support Level
- AAP $43.71
- APGE $36.48
- Resistance Level
- AAP $46.47
- APGE $42.98
- Average True Range (ATR)
- AAP 2.10
- APGE 2.92
- MACD
- AAP -0.20
- APGE -0.99
- Stochastic Oscillator
- AAP 41.88
- APGE 4.12
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto parts retailer in North America with more than 4,000 store and branch locations. About 55% of the firm's sales are geared toward the professional channel, with the remaining 45% going to the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units conducive to various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub and spoke distribution model critical to meeting customer needs.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.